公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks,and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications forapproved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
公司地址 11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
電話號碼 +1 908 967-6677
傳真號碼 --
公司網頁 https://www.citiusonc.com
員工數量 0
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jaime Bartushak Chief Financial Officer, Principal Accounting Officer, Treasurer and Chief Business Officer -- 23/12/2025
Mr. Leonard L. Mazur Chairman of the Board and Chief Executive Officer 美元 166.25K 23/12/2025
Mr. Myron Z. Holubiak Director and Secretary 美元 450.00K 23/12/2025
Dr. Myron Czuczman, M.D. Chief Medical Officer 美元 225.00K 23/12/2025
 
董事會成員
董事會 職務 更新日期
Dr. Eugene Holuka Independent Director 23/12/2025
Mr. Joel D. Mayersohn Independent Director 23/12/2025
Mr. Suren G. Dutia Lead Independent Director 23/12/2025
Mr. Robert J. Smith Independent Director 23/12/2025
Ms. Carol Webb Independent Director 23/12/2025
Mr. Dennis M. McGrath, C.P.A. Independent Director 23/12/2025
Mr. Leonard L. Mazur Chairman of the Board and Chief Executive Officer 23/12/2025
Mr. Myron Z. Holubiak Director and Secretary 23/12/2025
 
所屬ETF (更新日期: 02/05/2026 05:12)
代號 名稱 佔比% 持有日期
IWCiShares Micro-Cap ETF0.05%29/04/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.